Risk of bias assessment for eligible randomized controlled trials. by Junyin Pan (20700411)

Subjects:

S2 File - by Junyin Pan (20700411)

Subjects:

Funnel plot. by Junyin Pan (20700411)

Subjects:

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. by Junyin Pan (20700411)

Subjects:

The flow chart of study selection process. by Junyin Pan (20700411)

Subjects:

Data extracted from included studies for the systematic review and meta-analysis. by Junyin Pan (20700411)

Subjects:

Specifications and outcomes of clinical trial studies included in the meta-analysis. by Junyin Pan (20700411)

Subjects:

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Subjects:

Information of QTL interval and lead SNP significantly associated with meat color in fast-growing white-feathered chickens. by Jiahong Sun (6497603)

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

MXene/Bi₂O₃ Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the immuno-expressional level of NGF protein in maternal cerebellar tissue of different groups. by Amoura M. Abou-El-Naga (21001524)

“…Figs <b>(E & F):</b> Diabetic mothers have a significant decrease in the expression of NGF protein across all three layers of the cerebellar cortex. …”

The results of mediating mechanism test. by Le Zhu (1771669)

Subjects: